To establish and optimize the venous thromboembolism(VTE), whole process prevention and treatment information system based on electronic medical record system. Improving the convenience and efficiency of VTE prevention and control management to achieve continuous, dynamic, effective monitoring and other advantages of the management, reduce the incidence of VTE and improve medical quality and safety. Beijing Friendship Hospital established a hospital VTE prevention and treatment management system in 2020. Through the system management, it explores effective ways to prevent and manage VTE in hospitalized patients. This study took all hospitalized patients from January 1, 2020 to December 31, 2022 as the research subjects, and standardized diagnosis and treatment pathway was established based on clinical pathway. The hospital independently developed VTE prevention and management system, and built VTE assessment scales and risk assessment scales, based on the electronic medical record system of hospital information system. The relevant workload table is embedded in the electronic medical record. The system integrates clinical data, conducts unified analysis and structuring, realizes system functions such as VTE risk assessment, VTE risk warning, VTE standardized prevention and treatment, VTE quality control, etc. And evaluates and analyzes the implementation effect of the VTE prevention and management system in the hospital, comparing the VTE prevention and management effect of hospitalized patients before and after system management. The results showed that the medical staff′s awareness and ability of prevention and treatment of VTE were significantly improved. In 2020, the rate of VTE dynamic risk assessment reached to 55.9%, and which was increased to 88.0% in 2022( χ2=15 551.302, P<0.001). In 2020, the rate of VTE preventive measures was 22.8%, which was increased to 61.2% in 2022( χ2=4 669.675, P<0.001). In conclusion, the application of the hospital VTE prevention and treatment management system can effectively improve the standardization, scientific and management efficiency, which further ensure medical safety, and provide necessary decision support for clinical medicine.

Objective To explore the clinical efficacy,safety and changes in sexual function of 450 nm blue laser vaporization resection of the prostate in the treatment of benign prostatic hyperplasia(BPH).Methods The clinical data of 132 BPH patients treated in Yingsheng Branch of Taian Central Hospital during Jan.and Oct.2023 were retrospectively analyzed.The perioperative related indicators,incidence of complications were recorded.The international prostate symptoms(IPSS)score,maximum urine flow rate(Qmax),post voiding residual(PVR),quality of life score(QoL),prostate-specific antigen(PSA)level,the Chinese index of premature ejaculation score(CIPE)and international erectile function index-5(IIEF-5)score before operation,and 1,3,6,and 12 months after operation were analyze.Results The operation time was(18.37±5.38)min,intraoperative blood loss(6.73±2.57)mL,postoperative hospital stay(4.31±1.54)d,catheter indwelling time(2.45±1.27)d,and bladder irrigation time(19.61±2.45)h.There were significant differences in Qmax,PVR,PSA level,QoL and IPSS before and after operation(P＜0.05).There was no statistically significant difference in IIEF-5 and CIPE before operation and 3,6 and 12 months after operation(P＞0.05).The retrograde ejaculation rate remained 6.25％3,6 and 12 months after operation.Conclusion The 450 nm blue laser vaporization resection of the prostate can relieve lower urinary tract symptoms,preserve the sexual function,and improve patients'quality of life.

In the judicial appraisal of medical injury related to retinopathy of prematurity(ROP),evaluating the loss of visual rehabilitation opportunities for premature infants is crucial for determining liability.Based on the pathogenesis and progression of ROP,and with reference to diagnostic and treatment standards such as the Chinese Guidelines for Screening Retinopathy of Premature Infants(2014),we attempted to establish a multidimensional quantitative analysis framework that incorporates high-risk factor identification,fault-causation analysis,and loss-of-chance quantification.This framework provides a standardized and quantifiable technical pathway for the rational evaluation of rehabilitation opportunity loss in ROP-related medical injury identification.

To establish and optimize the venous thromboembolism(VTE), whole process prevention and treatment information system based on electronic medical record system. Improving the convenience and efficiency of VTE prevention and control management to achieve continuous, dynamic, effective monitoring and other advantages of the management, reduce the incidence of VTE and improve medical quality and safety. Beijing Friendship Hospital established a hospital VTE prevention and treatment management system in 2020. Through the system management, it explores effective ways to prevent and manage VTE in hospitalized patients. This study took all hospitalized patients from January 1, 2020 to December 31, 2022 as the research subjects, and standardized diagnosis and treatment pathway was established based on clinical pathway. The hospital independently developed VTE prevention and management system, and built VTE assessment scales and risk assessment scales, based on the electronic medical record system of hospital information system. The relevant workload table is embedded in the electronic medical record. The system integrates clinical data, conducts unified analysis and structuring, realizes system functions such as VTE risk assessment, VTE risk warning, VTE standardized prevention and treatment, VTE quality control, etc. And evaluates and analyzes the implementation effect of the VTE prevention and management system in the hospital, comparing the VTE prevention and management effect of hospitalized patients before and after system management. The results showed that the medical staff′s awareness and ability of prevention and treatment of VTE were significantly improved. In 2020, the rate of VTE dynamic risk assessment reached to 55.9%, and which was increased to 88.0% in 2022( χ2=15 551.302, P<0.001). In 2020, the rate of VTE preventive measures was 22.8%, which was increased to 61.2% in 2022( χ2=4 669.675, P<0.001). In conclusion, the application of the hospital VTE prevention and treatment management system can effectively improve the standardization, scientific and management efficiency, which further ensure medical safety, and provide necessary decision support for clinical medicine.

Objective To explore the clinical efficacy,safety and changes in sexual function of 450 nm blue laser vaporization resection of the prostate in the treatment of benign prostatic hyperplasia(BPH).Methods The clinical data of 132 BPH patients treated in Yingsheng Branch of Taian Central Hospital during Jan.and Oct.2023 were retrospectively analyzed.The perioperative related indicators,incidence of complications were recorded.The international prostate symptoms(IPSS)score,maximum urine flow rate(Qmax),post voiding residual(PVR),quality of life score(QoL),prostate-specific antigen(PSA)level,the Chinese index of premature ejaculation score(CIPE)and international erectile function index-5(IIEF-5)score before operation,and 1,3,6,and 12 months after operation were analyze.Results The operation time was(18.37±5.38)min,intraoperative blood loss(6.73±2.57)mL,postoperative hospital stay(4.31±1.54)d,catheter indwelling time(2.45±1.27)d,and bladder irrigation time(19.61±2.45)h.There were significant differences in Qmax,PVR,PSA level,QoL and IPSS before and after operation(P＜0.05).There was no statistically significant difference in IIEF-5 and CIPE before operation and 3,6 and 12 months after operation(P＞0.05).The retrograde ejaculation rate remained 6.25％3,6 and 12 months after operation.Conclusion The 450 nm blue laser vaporization resection of the prostate can relieve lower urinary tract symptoms,preserve the sexual function,and improve patients'quality of life.

In the judicial appraisal of medical injury related to retinopathy of prematurity(ROP),evaluating the loss of visual rehabilitation opportunities for premature infants is crucial for determining liability.Based on the pathogenesis and progression of ROP,and with reference to diagnostic and treatment standards such as the Chinese Guidelines for Screening Retinopathy of Premature Infants(2014),we attempted to establish a multidimensional quantitative analysis framework that incorporates high-risk factor identification,fault-causation analysis,and loss-of-chance quantification.This framework provides a standardized and quantifiable technical pathway for the rational evaluation of rehabilitation opportunity loss in ROP-related medical injury identification.

Background::Pancreatic ductal adenocarcinoma (PDAC) is one of the main types of malignant tumor of the digestive system, and patient prognosis is affected by difficulties in early diagnosis, poor treatment response, and a high postoperative recurrence rate. Carbohydrate antigen 19-9 (CA19-9) has been widely used as a biomarker for the diagnosis and postoperative follow-up of PDAC patients. Nevertheless, the production mechanism and potential role of CA19-9 in PDAC progression have not yet been elucidated.Methods::We performed single-cell RNA sequencing on six samples pathologically diagnosed as PDAC (three CA19-9-positive and three CA19-9-negative PDAC samples) and two paracarcinoma samples. We also downloaded and integrated PDAC samples (each from three CA19-9-positive and CA19-9-negative patients) from an online database. The dynamics of the proportion and potential function of each cell type were verified through immunofluorescence. Moreover, we built an in vitro coculture cellular model to confirm the potential function of CA19-9. Results::Three subtypes of cancer cells with a high ability to produce CA19-9 were identified by the markers TOP2A, AQP5, and MUC5AC. CA19-9 production bypass was discovered on antigen-presenting cancer-associated fibroblasts (apCAFs). Importantly, the proportion of immature ficolin-1 positive (FCN1+) macrophages was high in the CA19-9-negative group, and the proportion of mature M2-like macrophages was high in the CA19-9-positive group. High proportions of these two macrophage subtypes were associated with an unfavourable clinical prognosis. Further experiments indicated that CA19-9 could facilitate the transformation of M0 macrophages into M2 macrophages in the tumor microenvironment. Conclusions::Our study described CA19-9 production at single-cell resolution and the dynamics of the immune atlas in CA19-9-positive and CA19-9-negative PDAC. CA19-9 could promote M2 polarization of macrophage in the pancreatic tumor microenvironment.

Objective To explore the effects of transurethral blue laser vaporization of prostate for benign prostatic hyperplasia(BPH)on the sexual function and lower urinary tract symptoms.Methods A retrospective analysis was conducted on 91 BPH patients admitted to our department during Mar.and Aug.2023.The patients were divided into two groups,46 in the blue laser group,and 45 in the transurethral plasmakinetic resection of prostate(PKRP)group.The operation time,bladder irrigation time,catheter indwelling time and postoperative hospitalization time of the two groups were compared.Postvoid residual(PVR),maximum urinary flow rate(Qmax),international prostatic symptoms score(I PSS),quality of life score(QoL),international index of erectile function-5(IIEF-5)score,the Chinese index of premature ejaculation(CIPE)score and incidence of retrograde ejaculation were compared before and 6 months after operation.Results The operation time[(24.66±5.38)min vs.(62.50±3.85)min],bladder irrigation time[(20.40±2.78)h vs.(51.93±5.02)h],catheter indwelling time(1.65±0.89)d vs.(6.73±2.98)d]and postoperative hospitalization time[(4.26±1.57)d vs.(8.45±2.28)d]were significantly shorter in the blue laser group than in the PKRP group(P＜0.05).There were no significant differences in Qmax,PVR,QoL and IPSS between the two groups before and 6 months after operation(P＞0.05).Six months after surgery,the IIEF-5 score and CIPE score of the blue laser group were higher than those of the PKRP group[(20.02±2.63)vs.(17.64±1.75);(30.88±3.45)vs.(26.25±3.51)],but the incidence of retrograde ejaculation was lower(4.35％vs.35.60％),with statistical significance(P＜0.05).Conclusion Blue laser vaporization of the prostate can improve lower urinary tract symptoms and protect sexual function.

Objective To explore the application value of three-dimensional visualization technology in associating liver partition and portal vein ligation for staged hepatectomy (ALPPS). Methods Clinical data of one patient with hepatocellular carcinoma (HCC) undergoing ALPPS using three-dimensional visualization technology were analyzed retrospectively. The patient was female, aged 44 years, was hospitalized due to transaminase elevation for 3 months and solid hepatic lesion for 3 d. She had a history of hepatitis B. She was diagnosed with massive HCC in the right liver lobe. The informed consents of the patient was obtained and the local ethical committee approval was received. Preoperative evaluation and surgical planning were performed using computer tomography (CT) scan and medical imaging three-dimensional visualization system (MI-3DVS). Results Total liver volume was 1 033 ml and the left lobe volume was 195 ml, accounting for 16%of the standard liver volume measured by three-dimensional visualization technology before the ifrst-stage surgery. The right branch of portal vein was ligated and the left and right liver lobes were separated. Total liver volume was 1 048 ml and the left lobe volume was 394 ml, accounting for 33%of the standard liver volume measured by three-dimensional visualization technology 3 weeks after surgery. Right hemihepatectomy was performed during the second stage. The ifndings of preoperative three-dimensional visualization technology were consistent with intraoperative observation. Preoperative surgical planning was in accordance with intraoperative procedures. No apparent complication was observed after surgery. Conclusion Three-dimensional visualization technology is a favorable supplementary option for ALPPS in making the preoperative precise diagnosis and detailed surgical planning.

Objective To find the mutation of disease-causing genes of sudden unexplained death syn-drome (SU D S ) in the young by whole exome sequencing in one case. Methods O ne SU D S case was found no obvious fatal pathological changes after conventional autopsy and pathological examination. The whole exome sequencing was performed with the Ion Torrent PGMTM Systemwith hg19 as reference se-quence for sequencing data. The functions of mutations were analyzed by PhyloP, PolyPhen2 and SIFT. A three-step bioinformatics filtering procedure was carried out to identify possible significative single nu-cleotide variation (SN V ), which was missense mutation with allele frequency <1% of myocardial cell. Results Four rare suspicious pathogenic SN V were identified. C ombined with the analysis of convention-al autopsy and pathological examination, the mutation MYOM 2 (8_2054058_G/A ) was assessed as high-risk deleterious mutation by PolyPhen2 and SIFT, respectively. Conclusion Based on the second genera-tion sequencing technology, analysis of whole exome sequencing can be a newmethod for the death cause investigation of SU D S. The gene MYOM2 is a newcandidate SU D S pathogenic gene for mecha-nismresearch.